2003Journal of Clinical Internal MedicineRequires access

Diagnostic value of brain natriuretic peptide in congestive heart failure

HE Zuoyou

Open publisher page 0 citations

Abstract

Objective To evaluate diagnostic value of plasma brain natriuretic peptide(BNP) in patients with congestive heart failure(CHF).Methods 85 patients with acute dyspnea and whose B-type natriuretic peptide was measured with ELISA assay.The clinical diagnosis of congestive heart failure was adjudicated by two independent cardiologists,who were blinded to the results of the B-type natriuretic peptide assay.Thirty patients with normal ventricular function served as control group.Results The plasma BNP concentrations of CHF were significantly higher than that of non-CHF(P0.001 respectively),A plasma BNP concentration exceeding mean of the controls(x+1.96s) had a sensitivity of 96% and a specificity of 93% for diagnosis of congestive heart failure in patients with acute dyspnea.Conclusions Used in conjunction with other clinical information, measurement of B-type natriuretic peptide is useful in establishing or excluding the diagnosis of congestive heart failure in patients with acute dyspnea.

About this research paper

What this paper is about

Objective To evaluate diagnostic value of plasma brain natriuretic peptide(BNP) in patients with congestive heart failure(CHF).Methods 85 patients with acute dyspnea and whose B-type natriuretic peptide was measured with ELISA assay.The clinical diagnosis of congestive heart failure was adjudicated by two independent cardiologists,who were blinded to the results of the B-type natriuretic peptide assay.Thirty patients with normal ventricular function served as control group.Results The plasma BNP concentrations of CHF were significantly higher than that of non-CHF(P0.001 respectively),A plasma BNP concentration exceeding mean of the controls(x+1.96s) had a sensitivity of 96% and a specificity of 93% for diagnosis of congestive heart failure in patients with acute dyspnea.Conclusions Used in conjunction with other clinical information, measurement of B-type natriuretic peptide is useful in establishing or excluding the diagnosis of congestive heart failure in patients with acute dyspnea.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate diagnostic value of plasma brain natriuretic peptide(BNP) in patients with congestive heart failure(CHF).Methods 85 patients with acute dyspnea and whose B-type natriuretic peptide was measured with ELISA assay.The clinical diagnosis of congestive heart failure was adjudicated by two independent cardiologists,who were blinded to the results of the B-type natriuretic peptide assay.Thirty patients with normal ventricular function served as control group.Results The plasma BNP concentrations of CHF were significantly higher than that of non-CHF(P0.001 respectively),A plasma BNP concentration exceeding mean of the controls(x+1.96s) had a sensitivity of 96% and a specificity of 93% for diagnosis of congestive heart failure in patients with acute dyspnea.Conclusions Used in conjunction with other clinical information, measurement of B-type natriuretic peptide is useful in establishing or excluding the diagnosis of congestive heart failure in patients with acute dyspnea.

Key concepts: Heart failure, Medicine, Natriuretic peptide, Internal medicine, Cardiology, Brain natriuretic peptide

Related papers

Back to paper searchBrowse research topicsOriginal source
Diagnostic value of brain natriuretic peptide in congestive heart failure — Research Paper | ScholarLens